JM Stankiewicz
JM Stankiewicz
Assistant Professor, Harvard medical school
Verified email at
Cited by
Cited by
Iron in chronic brain disorders: imaging and neurotherapeutic implications
J Stankiewicz, SS Panter, M Neema, A Arora, CE Batt, R Bakshi
Neurotherapeutics 4 (3), 371-386, 2007
T1‐and T2‐based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis
M Neema, J Stankiewicz, A Arora, VSR Dandamudi, CE Batt, ZD Guss, ...
Journal of Neuroimaging 17, 16S-21S, 2007
Brain MRI lesion load at 1.5 T and 3T versus clinical status in multiple sclerosis
JM Stankiewicz, BI Glanz, BC Healy, A Arora, M Neema, RHB Benedict, ...
Journal of Neuroimaging 21 (2), e50-e56, 2011
MRI in multiple sclerosis: what’s inside the toolbox?
M Neema, J Stankiewicz, A Arora, ZD Guss, R Bakshi
Neurotherapeutics 4 (4), 602-617, 2007
Role of iron in neurotoxicity: a cause for concern in the elderly?
JM Stankiewicz, SD Brass
Current Opinion in Clinical Nutrition & Metabolic Care 12 (1), 22-29, 2009
The relationships among MRI‐defined spinal cord involvement, brain involvement, and disability in multiple sclerosis
AB Cohen, M Neema, A Arora, E Dell’Oglio, RHB Benedict, S Tauhid, ...
Journal of Neuroimaging 22 (2), 122-128, 2012
A probiotic modulates the microbiome and immunity in multiple sclerosis
SK Tankou, K Regev, BC Healy, E Tjon, L Laghi, LM Cox, P Kivisäkk, ...
Annals of Neurology 83 (6), 1147-1161, 2018
Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI study
JM Stankiewicz, M Neema, DC Alsop, BC Healy, A Arora, GJ Buckle, ...
Journal of the neurological sciences 279 (1-2), 99-105, 2009
Iron and multiple sclerosis
JM Stankiewicz, M Neema, A Ceccarelli
Neurobiology of aging 35, S51-S58, 2014
Normal findings on brain fluid-attenuated inversion recovery MR images at 3T
M Neema, ZD Guss, JM Stankiewicz, A Arora, BC Healy, R Bakshi
American Journal of Neuroradiology 30 (5), 911-916, 2009
Investigation of probiotics in multiple sclerosis
SK Tankou, K Regev, BC Healy, LM Cox, E Tjon, P Kivisakk, IP Vanande, ...
Multiple Sclerosis Journal 24 (1), 58-63, 2018
Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale
R Bakshi, M Neema, BC Healy, Z Liptak, RA Betensky, GJ Buckle, ...
Archives of neurology 65 (11), 1449-1453, 2008
A 3T MR imaging investigation of the topography of whole spinal cord atrophy in multiple sclerosis
JP Klein, A Arora, M Neema, BC Healy, S Tauhid, D Goldberg-Zimring, ...
American journal of neuroradiology 32 (6), 1138-1142, 2011
Nonfatal PML in a patient with multiple sclerosis treated with dimethyl fumarate
M Baharnoori, J Lyons, A Dastagir, I Koralnik, JM Stankiewicz
Neurology-Neuroimmunology Neuroinflammation 3 (5), 2016
Role of immunosuppressive therapy for the treatment of multiple sclerosis
JM Stankiewicz, H Kolb, A Karni, HL Weiner
Neurotherapeutics 10 (1), 77-88, 2013
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity
F Esposito, M Sorosina, L Ottoboni, ET Lim, JM Replogle, T Raj, ...
Annals of neurology 78 (1), 115-127, 2015
Levetiracetam for seizures after liver transplantation
GA Glass, J Stankiewicz, A Mithoefer, R Freeman, PR Bergethon
Neurology 64 (6), 1084-1085, 2005
Multiple sclerosis: diagnosis and therapy
HL Weiner, JM Stankiewicz
John Wiley & Sons, 2012
Experience with long-term rituximab use in a multiple sclerosis clinic
ME Barra, D Soni, KH Vo, T Chitnis, JM Stankiewicz
Multiple Sclerosis Journal–Experimental, Translational and Clinical 2 …, 2016
Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study
SA Gauthier, BI Glanz, M Mandel, A Tsagkaropoulos, M Neema, ...
Journal of the neurological sciences 284 (1-2), 116-119, 2009
The system can't perform the operation now. Try again later.
Articles 1–20